Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Aarschot, Belgium Clinical Trials

A listing of Aarschot, Belgium clinical trials actively recruiting patients volunteers.

RESULTS

Found (14) clinical trials

C-Leg 3 and C-Leg 4 Study in Transfemoral Amputees

During the last two decades many microprocessor controlled knee joints (MPK) appeared on the market.The newly developed C-Leg 4 aims to provide improved standing function while in the same time offering technology of knees previous version (C-Leg 3). Since added functional benefit of a knee joint cannot be anticipated just …

Phase

8.13 miles

Learn More »

Randomized Placebo-controlled Double-blind Study of 2LHERP in Orofacial Herpes Infections.

The study duration will be maximum 24 months with 12 months of inclusion and 12 months of follow-up. Patients aged between 18 and 80 years who present recurrent orofacial herpes infections (6 or more episodes within the 12-months' period prior to their study entry). The total number of patients to …

Phase

8.86 miles

Learn More »

An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis

Ulcerative colitis (UC) is a chronic inflammatory disease of the colon. Symptoms include bloody diarrhea, weight loss, and fever. There is no known cause or cure for UC. The aim of current UC treatments is to induce and maintain remission, to reduce the need of corticosteroids and avoid colectomy. Treatment …

Phase

9.43 miles

Learn More »

A Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study

Crohn's disease (CD) is a chronic inflammatory disease of the small bowel and colon. Symptoms commonly include bloody diarrhea, abdominal pain, weight loss, and fever. There is no known cause or cure for CD. The aim of current CD treatments is to induce and maintain remission, to reduce the need …

Phase

9.43 miles

Learn More »

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy

This is a randomized-controlled open-label trial comparing two different doses of low-molecular-weight heparin (LMWH) in pregnant patients with a history of previous venous thromboembolism (VTE). Both doses are recommended doses in the 2012 guidelines of the American College of Chest Physicians (ACCP), but it is not known which dose is …

Phase

9.43 miles

Learn More »

Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

This is a single-arm, open-label, multicenter, phase 4 clinical trial to evaluate the efficacy and safety of brentuximab vedotin as a single agent in patients with relapsed or refractory Systemic Anaplastic Large Cell Lymphoma (SALCL).

Phase

9.43 miles

Learn More »

Study of OCA Evaluating Pharmacokinetics and Safety in Patients With PBC and Hepatic Impairment

This Phase 4, randomized, double-blind, placebo-controlled study will evaluate the PK and safety of OCA treatment in patients with primary biliary cholangitis (PBC) and moderate to severe hepatic impairment over a 48 week treatment period. Patients who have completed their 48-week double blind treatment period will continue double-blind treatment until …

Phase

9.43 miles

Learn More »

European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)

The EuroEco is a prospective, international, randomized study aimed at assessing the economic effects of BIOTRONIK Home Monitoring (HM) technology as compared with traditional follow up (FU) of ICD and CRT-D patients from two perspectives: 1) the cost-effectiveness for the payer of health care, and 2) the economic impact on …

Phase

9.43 miles

Learn More »

Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose

Objective: To assess the incidence of post-TIPS OHE within the first three months after prophylactic administration of lactulose and rifaximin versus placebo in patients who undergo Transjugular Intrahepatic Portosystemic Shunt (TIPS) placement. Study design: A multicentre, randomized, placebo-controlled, double blind study. Study population: Adult consecutive patients undergoing elective TIPS placement …

Phase

9.43 miles

Learn More »

Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis

This Phase 4, double-blind, randomized, placebo-controlled, multicenter study is being undertaken at up to 170 sites internationally to evaluate the effect of OCA on clinical outcomes in 428 subjects with PBC. The study will include a screening period of up to 8 weeks, requiring two clinic visits. Eligible participants will …

Phase

9.43 miles

Learn More »